Our R&D division is led by technical experts, with extensive experience in leading domestic and international pharmaceutical enterprises as well as pharmaceutical R&D institution. The team has mastered multiple core technologies in complex drugs development. With deep expertise in Chinese and U.S. patent regulations and comprehensive knowledge of global drug registration policies, they hold dozens of independently developed intellectual property patents, and have achieved multiple success in patent challenges.